Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-28

Clinical Trial Update: The Value of CT Cholangiography in Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CT cholangiography for primary sclerosing cholangitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: WITHDRAWN